Myeloma UK launches ‘world first’ immunotherapy trial – PharmaTimes
PharmaTimes |
Myeloma UK launches 'world first' immunotherapy trial
PharmaTimes Myeloma UK has launched a ground-breaking immunotherapy trial which aims to modulate the immune system to target myeloma. In what the charity describes as a “world first”, the Phase Ib study, called MUK eleven, will investigate Oncolytics Biotech' … |
